paroxetine has been researched along with fluorodeoxyglucose f18 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derbyshire, S; Dew, MA; Houck, PR; Kupfer, DJ; Meltzer, CC; Milko, D; Nofzinger, E; Pollock, B; Reynolds, CF; Smith, GS | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Colgan, M; Dunkin, JJ; Maidment, KM; Phelps, ME; Saxena, S | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Fairbanks, LA; Huang, SC; Maidment, K; Phelps, ME; Saxena, S; Silverman, DH; Wu, HM | 1 |
| Arifuzzman, AI; Evans, KR; Houle, S; Kennedy, SH; Krüger, S; Mayberg, HS; McCann, S; Meyer, JH; Vaccarino, FJ | 1 |
| Alborzian, S; Au, SC; Baxter, LR; Brody, AL; Fairbanks, LA; Gillies, LA; Ho, MK; Ho, ML; Huang, SC; Maidment, K; Phelps, ME; Saxena, S; Stoessel, P; Wu, HM | 1 |
| Baxter, LR; Brody, AL; Fairbanks, LA; Ho, ML; Mandelkern, MA; Saxena, S | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Ho, MK; Ho, ML; Huang, SC; Maidment, KM; Saxena, S; Wu, HM; Zohrabi, N | 1 |
| Bolwig, TG; Hansen, ES; Hasselbalch, S; Law, I | 1 |
| Baxter, LR; Brody, AL; Ho, ML; Maidment, KM; Saxena, S; Zohrabi, N | 1 |
| Bieling, P; Garson, C; Goldapple, K; Kennedy, S; Lau, M; Mayberg, H; Segal, Z | 1 |
| Goldapple, K; Kennedy, S; Mayberg, HS; McIntosh, AR; Rafi-Tari, S; Segal, Z; Seminowicz, DA | 1 |
| Eipper, F; Lee, L; Malone, K; Mann, JJ; Milak, MS; Olvet, DM; Oquendo, MA; Parsey, RV | 1 |
| Apostolova, I; Block, S; Buchert, R; Clausen, M; Conradi, M; Fricke, S; Gensichen, S; Hand, I; Obrocki, J; Osen, B; Rufer, M; Schröder-Hartwig, K; Tabrizian, S; Weiss, A | 1 |
| Ciliberto, M; De Crescenzo, F; Ebmeier, KP; Janiri, L; Menghini, D; Treglia, G | 1 |
1 review(s) available for paroxetine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Is
Topics: Aged; Aging; Blood Glucose; Brain; Case-Control Studies; Depression; Fluorodeoxyglucose F18; Humans; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Deprivation | 2017 |
3 trial(s) available for paroxetine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.
Topics: Age Factors; Aged; Antidepressive Agents, Second-Generation; Brain; Combined Modality Therapy; Depressive Disorder; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Psychiatric Status Rating Scales; Sleep; Sleep Deprivation; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.
Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Thalamus; Tomography, Emission-Computed; Treatment Outcome | 2001 |
The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.
Topics: Adult; Caudate Nucleus; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed | 2002 |
10 other study(ies) available for paroxetine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.
Topics: Cerebral Cortex; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed | 1999 |
Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Depressive Disorder, Major; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
Topics: Adult; Brain; Depressive Disorder; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Hippocampus; Humans; Limbic System; Male; Middle Aged; Parietal Lobe; Paroxetine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Brain metabolic changes associated with symptom factor improvement in major depressive disorder.
Topics: Depressive Disorder, Major; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Paroxetine; Prefrontal Cortex; Psychomotor Disorders; Psychotherapy; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
Topics: Adult; Blood Glucose; Brain; Brain Mapping; Comorbidity; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Inventory; Radiography; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Prefrontal Cortex; Probability; Prognosis; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Limbic System; Male; Middle Aged; Nerve Net; Neural Pathways; Outcome and Process Assessment, Health Care; Paroxetine; Personality Inventory; Prefrontal Cortex; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Limbic-frontal circuitry in major depression: a path modeling metanalysis.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Drug Resistance; Electroconvulsive Therapy; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Limbic System; Models, Neurological; Nerve Net; Paroxetine; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Mesencephalon; Middle Aged; Paroxetine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.
Topics: Adult; Analysis of Variance; Brain; Brain Mapping; Cognitive Behavioral Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Linear Models; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2010 |